Ridgeback Capital — 2016 Investments

2 investments dated 2016 · listed companies and verified rows first · show all

Ironwood Pharmaceuticalsironwoodpharma.com in 𝕏Sep 2016

Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing treatments for GI diseases.

BiotechDigital HealthHealthtechCambridge, US

PETER M. HECHT(Executive Officer, Director)inMARK G. CURRIE(Executive Officer)inHALLEY E. GIBLERT(Executive Officer)THOMAS GRANEY(Executive Officer)THOMAS A. MCCOURT(Executive Officer)in

BoardTERRANCE G. MCGUIRE(Director)

Co-investorsF-Prime Capital Mountain Group Capital Venrock Maverick Ventures Polaris Partners

Mersana Therapeuticsmersana.com 𝕏Jun 2016Acquired

Day One (part of Servier) is a biopharmaceutical company developing targeted oncology medicines, with a focus on cancers affecting patients of all ages, including pediatric low-grade glioma (pLGG).

BiotechHealthtechCambridge, US

MICHAEL J. KAUFMAN(Executive Officer)inDonald Bergstrom(Executive Officer)inANNA PROTOPAPAS(Executive Officer, Director)Timothy Lowinger(Executive Officer)Eva Jack(Executive Officer)Wayne Foster(Executive Officer)

Co-investorsBain Capital Life Sciences F-Prime Capital Lightstone Ventures New Enterprise Associates (NEA)Nextech Invest Pfizer Venture Investments +3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.